NASDAQ:BCYC

Bicycle Therapeutics Stock Insider Trading

Healthcare > Biotechnology

Buy BCYC

*Your capital is at risk

$4.35

-0.0600 (-1.36%)

At Close: Jul 13, 2026

Bicycle Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 61.94. In total, the insiders bought 1.84M and sold 97.67K BCYC shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	61.94
● Buy	1.84M shares
● Sell	97.67K shares
40% Buy Activity Strong Negative Correlation
Sell Signal Low Confidence Jul 02, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 61.94. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jul 06, 2026 Sell	Ordinary Shares S-Sale	Thompson Travis Alvin Chief Financial Officer	C-Suite Officer	104 Value: $448
Jul 06, 2026 Sell	Ordinary Shares S-Sale	Hannay Michael Charles Ferguson Chief Prod & Supply Chain Off	Officer	255 Value: $1K
Jul 06, 2026 Sell	Ordinary Shares S-Sale	Perry Jennifer Scott Chief Operating Officer	C-Suite Officer	333 Value: $1K
Jul 06, 2026 Sell	Ordinary Shares S-Sale	Perry Jennifer Scott Chief Operating Officer	C-Suite Officer	43 Value: $185
Jul 06, 2026 Sell	Ordinary Shares S-Sale	Skynner Michael Chief Scientific Officer	Officer	532 Value: $2K
Jul 06, 2026 Sell	Ordinary Shares S-Sale	Lee Kevin Chief Executive Officer	CEO / President	1 737 Value: $7K
Jul 02, 2026 Sell	Ordinary Shares S-Sale	Lee Kevin Chief Executive Officer	CEO / President	5 905 Value: $25.2K
Jul 02, 2026 Sell	Ordinary Shares S-Sale	Perry Jennifer Scott Chief Operating Officer	C-Suite Officer	1 036 Value: $4K
Jul 02, 2026 Sell	Ordinary Shares S-Sale	Skynner Michael Chief Scientific Officer	Officer	1 859 Value: $8K
Jul 02, 2026 Sell	Ordinary Shares S-Sale	Hannay Michael Charles Ferguson Chief Prod & Supply Chain Off	Officer	1 506 Value: $6K
Jul 02, 2026 Sell	Ordinary Shares S-Sale	Thompson Travis Alvin Chief Financial Officer	C-Suite Officer	819 Value: $3K
Apr 06, 2026 Sell	Ordinary Shares S-Sale	Skynner Michael Chief Scientific Officer	Officer	525 Value: $3K
Apr 06, 2026 Sell	Ordinary Shares S-Sale	Perry Jennifer Scott Chief Operating Officer	C-Suite Officer	333 Value: $2K
Apr 06, 2026 Sell	Ordinary Shares S-Sale	Hannay Michael Charles Ferguson Chief Prod & Supply Chain Off	Officer	251 Value: $1K
Apr 06, 2026 Sell	Ordinary Shares S-Sale	Thompson Travis Alvin Chief Financial Officer	C-Suite Officer	102 Value: $515
Apr 06, 2026 Sell	Ordinary Shares S-Sale	Perry Jennifer Scott Chief Operating Officer	C-Suite Officer	37 Value: $187
Apr 06, 2026 Sell	Ordinary Shares S-Sale	Lee Kevin Chief Executive Officer	CEO / President	1 716 Value: $9K
Apr 02, 2026 Sell	Ordinary Shares S-Sale	Perry Jennifer Scott Chief Operating Officer	C-Suite Officer	1 038 Value: $5K
Apr 02, 2026 Sell	Ordinary Shares S-Sale	Thompson Travis Alvin Chief Financial Officer	C-Suite Officer	799 Value: $4K
Apr 02, 2026 Sell	Ordinary Shares S-Sale	Hannay Michael Charles Ferguson Chief Prod & Supply Chain Off	Officer	1 521 Value: $7K
Apr 02, 2026 Sell	Ordinary Shares S-Sale	Lee Kevin Chief Executive Officer	CEO / President	5 967 Value: $29.3K
Apr 02, 2026 Sell	Ordinary Shares S-Sale	Skynner Michael Chief Scientific Officer	Officer	1 879 Value: $9K
Mar 17, 2026 Buy	Employee Stock Option (right to buy)	Perry Jennifer Scott Chief Operating Officer	C-Suite Officer	58 000 Value: $1.31M
Mar 17, 2026 Buy	Employee Stock Option (right to buy)	Perry Jennifer Scott Chief Operating Officer	C-Suite Officer	3 576 Value: $105.8K
Mar 17, 2026 Buy	Employee Stock Option (right to buy)	Perry Jennifer Scott Chief Operating Officer	C-Suite Officer	20 000 Value: $529.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT BICYCLE THERAPEUTICS PLC

Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The company's oncology product candidates also comprise BT5528, a BTC that is in a Phase I/II clinical trial ...

Read Full Profile Here